Tomas G Olsson
1 – 10 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease
Mattsson, Niklas LU ; Insel, Philip S. LU ; Donohue, Michael ; Jögi, Jonas LU
;
Ossenkoppele, Rik
LU
;
Olsson, Tomas
LU
;
Schöll, Michael
LU
;
Smith, Ruben
LU
and
Hansson, Oskar
LU
(2019)
In Alzheimer's and Dementia
15(4).
p.570-580
Mark
- Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of [ 18 F]ENL30 : A Potential PET Radiotracer for the 5-HT 7 Receptor
- 2017
-
Modeling strategies for quantification of in vivo 18F-AV1451 binding in patients with tau pathology
Hahn, Andreas ; Schain, Martin ; Erlandsson, Maria ; Sjölin, Petter ; James, Gregory ; Strandberg, Olof LU ; Hägerström, Douglas LU ; Lanzenberger, Rupert ; Jögi, Jonas LU
and
Olsson, Tomas G
LU
, et al.
(2017)
In Journal of Nuclear Medicine
58(4).
p.623-631
Mark
-
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Sundlöv, Anna LU
;
Sjögreen-Gleisner, Katarina
LU
;
Svensson, Johanna
;
Ljungberg, Michael
LU
;
Olsson, Tomas G
LU
;
Bernhardt, Peter
and
Tennvall, Jan
LU
(2017)
In European Journal of Nuclear Medicine and Molecular Imaging
44(9).
p.1480-1489
Mark
-
Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy
Smith, Ruben LU ; Schain, Martin ; Nilsson, Christer LU ; Strandberg, Olof LU ; Olsson, Tomas LU ; Hägerström, Douglas LU ; Jögi, Jonas LU
;
Borroni, Edilio
;
Schöll, Michael
LU
and
Honer, Michael
, et al.
(2017)
In Movement Disorders
32(1).
p.108-114
Mark
- 2015
- Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.
- Role of CD8-positive cells in radioimmunotherapy utilizing (177)Lu-mAbs in an immunocompetent rat colon carcinoma model.
- 2014
- Change in Cell Death Markers During (177)Lu-mAb Radioimmunotherapy-Induced Rejection of Syngeneic Rat Colon Carcinoma.
- Sequential Radioimmunotherapy with (177)Lu- and (211)At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model.
- (18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.